Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511]

Abstract

The authors regret that there has been an error published within Fig. 5 of this article. The authors inadvertently pasted the anti-spike plots for the “≥70 years” group instead of the pseudo-neutralising antibody plots (pages 808–809) to Fig. 5A and B. These plots replicate the “≥70 years” group in Fig. 4A and B on pages 806–807. The authors have confirmed that the error does not affect the interpretation of the results and the rest of the paper, and the plots for the “<70 years” group in Fig. 5 are correct. The revised Fig. 5 contains the correct plots for pseudo-neutralising antibody data has now been updated in the original publication. The authors would like to apologise for any inconvenience caused.

Metadata

Item Type:	Article
Authors/Creators:	Liu, X. Munro, A.P. Feng, S. Janani, L. Aley, P.K. Babbage, G. Baxter, D. Bula, M. Cathie, K. Chatterjee, K. Dejnirattisai, W. Dodd, K. Enever, Y. Qureshi, E. Goodman, A.L. Green, C.A. Harndahl, L. Haughney, J. Hicks, A. van der Klaauw, A.A. Kwok, J. Libri, V. Llewelyn, M.J. McGregor, A.C. Minassian, A.M. Moore, P. Mughal, M. Mujadidi, Y.F. Holliday, K. Osanlou, O. Osanlou, R. Owens, D.R. Pacurar, M. Palfreeman, A. Pan, D. Rampling, T. Regan, K. Saich, S. Serafimova, T. Saralaya, D. Screaton, G.R. Sharma, S. Sheridan, R. Sturdy, A. Supasa, P. Thomson, E.C. Todd, S. Twelves, C. Read, R.C. Charlton, S. Hallis, B. Ramsay, M. Andrews, N. Lambe, T. Nguyen-Van-Tam, J.S. Cornelius, V. Snape, M.D. Faust, S.N. group, T.C.-B.S.
Commentary on:	Liu, X., Munro, A.P.S., Feng, S. et al. (56 more authors) (2022) Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial. Journal of Infection, 84 (6). pp. 795-813. ISSN: 0163-4453
Copyright, Publisher and Additional Information:	© 2023 The Author(s). This is an open access article under the terms of the Creative Commons Attribution License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
Dates:	Published (online): 11 April 2023 Published: May 2023
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Date Deposited:	27 Oct 2025 16:55
Last Modified:	27 Oct 2025 16:55
Status:	Published
Publisher:	Elsevier
Identification Number:	10.1016/j.jinf.2023.03.025
Sustainable Development Goals:
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:233594

Commentary/Response Threads

Liu, X., Munro, A.P.S., Feng, S., Janani, L., Aley, P.K., Babbage, G., Baxter, D., Bula, M., Cathie, K., Chatterjee, K., Dejnirattisai, W., Dodd, K., Enever, Y., Qureshi, E., Goodman, A.L., Green, C.A., Harndahl, L., Haughney, J., Hicks, A., van der Klaauw, A.A., Kwok, J., Libri, V., Llewelyn, M.J., McGregor, A.C., Minassian, A.M., Moore, P., Mughal, M., Mujadidi, Y.F., Holliday, K., Osanlou, O., Osanlou, R., Owens, D.R., Pacurar, M., Palfreeman, A., Pan, D., Rampling, T., Regan, K., Saich, S., Serafimova, T., Saralaya, D., Screaton, G.R., Sharma, S., Sheridan, R., Sturdy, A., Supasa, P., Thomson, E.C., Todd, S., Twelves, C., Read, R.C., Charlton, S., Hallis, B., Ramsay, M., Andrews, N., Lambe, T., Nguyen-Van-Tam, J.S., Cornelius, V., Snape, M.D., Faust, S.N. and group, T.C.-B.S. Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial. (deposited 27 Oct 2025 11:41)
- Liu, X., Munro, A.P., Feng, S., Janani, L., Aley, P.K., Babbage, G., Baxter, D., Bula, M., Cathie, K., Chatterjee, K., Dejnirattisai, W., Dodd, K., Enever, Y., Qureshi, E., Goodman, A.L., Green, C.A., Harndahl, L., Haughney, J., Hicks, A., van der Klaauw, A.A., Kwok, J., Libri, V., Llewelyn, M.J., McGregor, A.C., Minassian, A.M., Moore, P., Mughal, M., Mujadidi, Y.F., Holliday, K., Osanlou, O., Osanlou, R., Owens, D.R., Pacurar, M., Palfreeman, A., Pan, D., Rampling, T., Regan, K., Saich, S., Serafimova, T., Saralaya, D., Screaton, G.R., Sharma, S., Sheridan, R., Sturdy, A., Supasa, P., Thomson, E.C., Todd, S., Twelves, C., Read, R.C., Charlton, S., Hallis, B., Ramsay, M., Andrews, N., Lambe, T., Nguyen-Van-Tam, J.S., Cornelius, V., Snape, M.D., Faust, S.N. and group, T.C.-B.S. Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511]. (deposited 27 Oct 2025 16:55) [Currently Displayed]

Download

Published Version

Filename: PIIS0163445323001986 (1).pdf

Licence: CC-BY 4.0

CLICK TO DOWNLOAD

[thumbnail of PIIS0163445323001986 (1).pdf]

CORE (COnnecting REpositories)